Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank

Predictive Accuracy of a Polygenic Risk Score–Enhanced Prediction Model vs a Clinical Risk Score for Coronary Artery Disease

(2020) Joshua Elliott et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The Association Between Type 2 Diabetes Mellitus and Parkinson’s Disease

(2020) Julia L.Y. Cheong et al.   Journal of Parkinsons Disease

The illusion of polygenic disease risk prediction

(2019) Nicholas J. Wald et al.   GENETICS IN MEDICINE

Predicting diagnosis of Parkinson's disease: A risk algorithm based on primary care presentations

(2019) Anette Schrag et al.   MOVEMENT DISORDERS

Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

(2019) Valery L Feigin et al.   LANCET NEUROLOGY

Polygenic Risk Scores That Predict Common Diseases Using Millions of Single Nucleotide Polymorphisms: Is More, Better?

(2019) A. Cecile J.W. Janssens et al.   CLINICAL CHEMISTRY

Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms

(2019) Cornelis Blauwendraat et al.   MOVEMENT DISORDERS

Towards clinical utility of polygenic risk scores

(2019) Samuel A Lambert et al.   HUMAN MOLECULAR GENETICS

Update of the MDS research criteria for prodromal Parkinson's disease

(2019) Sebastian Heinzel et al.   MOVEMENT DISORDERS

Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s disease

(2019) Hampton Leonard et al.   JOURNAL OF MEDICAL GENETICS

Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

(2019) Mike A Nalls et al.   LANCET NEUROLOGY

British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction in Men—2017

(2018) Geoff Hackett et al.   Journal of Sexual Medicine

Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study

(2018) Philipp Mahlknecht et al.   MOVEMENT DISORDERS

The UK Biobank resource with deep phenotyping and genomic data

(2018) Clare Bycroft et al.   NATURE

Collider scope: when selection bias can substantially influence observed associations

(2017) Marcus R Munafò et al.   INTERNATIONAL JOURNAL OF EPIDEMIOLOGY

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

(2017) Dilan Athauda et al.   LANCET

PREDICT-PD: An online approach to prospectively identify risk indicators of Parkinson's disease

(2017) Alastair J. Noyce et al.   MOVEMENT DISORDERS

Gene-environment interactions linking air pollution and inflammation in Parkinson's disease

(2016) Pei-Chen Lee et al.   ENVIRONMENTAL RESEARCH

Genome-wide gene-environment interaction analysis of pesticide exposure and risk of Parkinson's disease

(2016) Joanna M. Biernacka et al.   PARKINSONISM & RELATED DISORDERS

Genetic risk of Parkinson’s disease in the general population

(2016) Sirwan K.L. Darweesh et al.   PARKINSONISM & RELATED DISORDERS

New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction

(2016) Howard J. Hoffman et al.   REVIEWS IN ENDOCRINE & METABOLIC DISORDERS

Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study

(2015) Mike A Nalls et al.   LANCET NEUROLOGY

A global reference for human genetic variation

(2015) Richard A. Gibbs et al.   NATURE

UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age

(2015) Cathie Sudlow et al.   PLOS MEDICINE

Prolactin and sex hormones levels in males with Parkinson's disease

(2014) M. Nitkowska et al.   ACTA NEUROLOGICA SCANDINAVICA

Sex differences in Parkinson's disease and other movement disorders

(2014) Kara M. Smith et al.   EXPERIMENTAL NEUROLOGY

Sex differences in Parkinson’s disease

(2014) Glenda E. Gillies et al.   FRONTIERS IN NEUROENDOCRINOLOGY

PREDICT-PD: Identifying risk of Parkinson's disease in the community: methods and baseline results

(2013) A. J. Noyce et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Meta-analysis of early nonmotor features and risk factors for Parkinson disease

(2012) Alastair J. Noyce et al.   ANNALS OF NEUROLOGY

Genetic modification of the association of paraquat and Parkinson's disease

(2012) Samuel M. Goldman et al.   MOVEMENT DISORDERS

Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study)

(2012) Joaquim Mullol et al.   BMJ Open

Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease

(2011) Hui-Ming Gao et al.   PROGRESS IN NEUROBIOLOGY

Genome-Wide Gene-Environment Study Identifies Glutamate Receptor Gene GRIN2A as a Parkinson's Disease Modifier Gene via Interaction with Coffee

(2011) Taye H. Hamza et al.   PLoS Genetics

Neuroprotective actions of sex steroids in Parkinson’s disease

(2009) Mélanie Bourque et al.   FRONTIERS IN NEUROENDOCRINOLOGY